Pertussis Completed Phase 4 Trials for Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) (DB10787)

Also known as: Whooping cough due to Bordetella pertussis / Whooping Cough / Whooping cough due to bordetella pertussis (B. pertussis)

IndicationStatusPhase
DBCOND0014696 (Pertussis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00802867Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™Prevention
NCT01659996Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of AgePrevention